IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,396,250 | +44.7% | 375,000 | +150.0% | 0.94% | +34.7% |
Q2 2022 | $1,656,000 | +333.5% | 150,000 | +650.0% | 0.70% | +402.2% |
Q4 2021 | $382,000 | -89.7% | 20,000 | -86.7% | 0.14% | -85.1% |
Q3 2021 | $3,699,000 | +42.2% | 150,000 | +50.0% | 0.93% | +0.2% |
Q2 2021 | $2,602,000 | +234.0% | 100,000 | +306.5% | 0.93% | +251.7% |
Q1 2021 | $779,000 | -14.3% | 24,600 | +25.5% | 0.26% | -45.0% |
Q4 2020 | $909,000 | – | 19,600 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |